课题基金 / 基金详情

Heparan sulfate - a master regulator of matrix metalloproteinase biology?

Heparan sulfate - a master regulator of matrix metalloproteinase biology?
硫酸乙酰肝素 - 基质金属蛋白酶生物学的主要调节剂?
批准号:
415888450
负责人:
Dr. Philipp Kastl
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Fellowships
财政年份:
2018
资助国家:
德国
项目状态:
已结题
起止时间:
2017-12-31 至 2020-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
信号蛋白的胞外切割是一种不可逆的翻译后修饰,在细胞外信号传递过程中起关键作用。为了更好地表征这种调控过程并了解其相关的病理情况,基于质谱学(MS)的蛋白质组学方法被开发出来,这种方法允许在体外和体内将底物处理与蛋白酶联系起来。然而,到目前为止,蛋白水解酶的筛选通常是人工的,并不能解释蛋白水解酶如何在体内以特定的和生理上相关的方式裂解底物。这种差异的原因之一可能是细胞外基质(ECM)不仅是许多蛋白酶的底物,就像基质金属蛋白酶(MMPs)家族的成员一样,而且通过结合许多底物和蛋白酶在调节细胞外蛋白分解过程中发挥积极作用。硫酸乙酰肝素(HS)蛋白多糖(HSPGs)是细胞外基质的重要组成部分,通过其不同的硫酸化HS侧链与多种形态因子、细胞因子和趋化因子结合,从而调节其生物活性。这增加了HS通过与相关分子结合和共定位来调节蛋白酶底物专一性的可能性,以及HS直接调节底物裂解位点可及性或蛋白酶活性的可能性。在我的博士论文中,我已经展示了HS在形态发生因子Hedgehog的切割和释放中的调节作用。现在,我的目标是通过比较不同HS表达的脊椎动物细胞系的分泌体,利用丹麦技术大学Ulrich auf DEM Keller教授的实验室开发并应用的最先进的MS蛋白质组学技术,来表征HS是细胞外蛋白分解的主要调节因子。许多MMPs与HS特异结合,因此这些细胞系也将被用来确定HS对炎症相关分泌型蛋白酶MMP9的活性和特异性、对其底物的稳定性和差异性处理以及对蛋白酶水平的影响。最后,将在不同HS变体存在的情况下,用选定的趋化因子候选来研究HS调制的MMP9切割。依赖HS的底物切割将通过已知的趋化因子活性分析和靶向蛋白质组学来验证。所获得的数据不仅将使MS-蛋白酶的筛选更具生理学意义,而且还将为全球范围内基质调控的胞外蛋白分解提供新的见解。
英文摘要
Extracellular cleavage of signaling proteins such as morphogens, cytokines or chemokines, an irreversible post-translational modification, is crucial for extracellular signaling processes of cells. In order to better characterize such regulatory processes and understand their associated pathological situations, novel mass spectrometry (MS)-based proteomics methods have been developed, which allowed linking substrate processing to proteases in vitro and in vivo. However, to date, protease screenings are often artificial and do not explain how proteases cleave their substrates in a specific and physiologically relevant manner in vivo. One reason for this discrepancy may be that the extracellular matrix (ECM) not only serves as a substrate for many proteases, like members of the matrix metalloproteinase (MMP) family, but also plays an active role in regulating extracellular proteolysis by binding many substrates and proteases. Heparan sulfate (HS) proteoglycans (HSPGs), which are important ECM components, bind many morphogens, cytokines, and chemokines via their variably sulfated HS side chains and thereby regulate their biological activity. This raises the possibilities that HS regulates protease substrate specificity by binding to and co-localizing the molecules involved and that HS directly modulates substrate cleavage site accessibility or protease activity. During my PhD thesis I could already show such a regulatory role of HS in the cleavage and release of the morphogen Hedgehog. Now, I aim to characterize HS as one main regulator of extracellular proteolysis by comparing the secretomes of vertebrate cell lines with different HS expression through novel state-of-the-art MS proteomics technologies, developed and applied in the laboratory of Prof. Dr. Ulrich auf dem Keller at the Technical University of Denmark. Many MMPs specifically bind to HS, thus these cell lines will also be used to determine the effect of HS on the activity and specificity of the inflammation related secreted protease MMP9, on the stability and differential processing of its substrates, and on the protease level. Lastly, HS-modulated MMP9 cleavage will be studied with selected chemokine candidates in the presence of different HS variants. HS-dependent substrate cleavage will be verified biochemically, with known chemokine activity assays and targeted proteomics. The data obtained will not only make MS-protease screenings more physiological relevant, but also provide novel insights into matrix regulated extracellular proteolysis on a global scale.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.bbapap.2020.140392
发表时间: 2020-02
期刊: Biochimica et biophysica acta. Proteins and proteomics
影响因子: --
作者: [Simonas Savickas;Philipp Kastl;U. A. D. Keller]
通讯作者: Simonas Savickas;Philipp Kastl;U. A. D. Keller
国内基金
海外基金
3-indoxyl sulfate-AhR-CYP450轴调控心肾交互增强化疗心脏毒性的作用及机制研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    黄统生
  • 依托单位:
3-indoxyl sulfate-AhR-CYP450轴调控心肾交互增强化疗心脏毒性的作用及机制研究
  • 批准号:
    82400433
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2024
  • 负责人:
    黄统生
  • 依托单位: